Cargando…
Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
Digestive tract cancers, including esophageal, gastric, and colorectal cancers, are the major cause of death among cancer patients worldwide due to the heterogeneity of cancer cells, which limits the effectiveness of traditional treatment methods. Immunotherapy represents a promising treatment strat...
Autores principales: | Ai, Huihan, Yang, Hang, Li, Liang, Ma, Jie, Liu, Kangdong, Li, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311965/ https://www.ncbi.nlm.nih.gov/pubmed/37398650 http://dx.doi.org/10.3389/fimmu.2023.1190883 |
Ejemplares similares
-
Dickkopf-1: A Promising Target for Cancer Immunotherapy
por: Chu, Hang Yin, et al.
Publicado: (2021) -
UPS: Opportunities and challenges for gastric cancer treatment
por: Yang, Hang, et al.
Publicado: (2023) -
CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
por: Jakobsen, Mie K., et al.
Publicado: (2020) -
Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
por: Yousef, Sara, et al.
Publicado: (2015) -
Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)